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Trials to Improve Blood Pressure Through Adherence
to Antihypertensives in Stroke/TIA: Systematic Review
and Meta-Analysis
Anna De Simoni, PhD; Wendy Hardeman, PhD; Jonathan Mant, MD; Andrew J. Farmer, DM; Ann Louise Kinmonth, MD
Background-—The purpose of this study was to determine whether interventions including components to improve adherence to
antihypertensive medications in patients after stroke/transient ischemic attack (TIA) improve adherence and blood pressure
control.
Methods and Results-—We searched MEDLINE, EMBASE, CINAHL, BNI, PsycINFO, and article reference lists to October 2012.
Search terms included stroke/TIA, adherence/prevention, hypertension, and randomized controlled trial (RCT). Inclusion criteria
were participants with stroke/TIA; interventions including a component to improve adherence to antihypertensive medications;
and outcomes including blood pressure, antihypertensive adherence, or both. Two reviewers independently assessed studies to
determine eligibility, validity, and quality. Seven RCTs were eligible (n=1591). Methodological quality varied. All trials tested
multifactorial interventions. None targeted medication adherence alone. Six trials measured blood pressure and 3 adherence.
Meta-analysis of 6 trials showed that multifactorial programs were associated with improved blood pressure control. The difference
between intervention versus control in mean improvement in systolic blood pressure was 5.3 mm Hg (95% CI, 10.2 to
0.4 mm Hg, P=0.035; I2=67% [21% to 86%]) and in diastolic blood pressure was 2.5 mm Hg (5.0 to 0.1 mm Hg, P=0.046;
I2=47% [0% to 79%]). There was no effect on medication adherence where measured.
Conclusions-—Multifactorial interventions including a component to improve medication adherence can lower blood pressure after
stroke/TIA. However, it is not possible to say whether or not this is achieved through better medication adherence. Trials are
needed of well-characterized interventions to improve medication adherence and clinical outcomes with measurement along the
hypothesized causal pathway. ( J Am Heart Assoc. 2013;2:e000251 doi: 10.1161/JAHA.113.000251)
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T he number of strokes and their impact on morbidity andmortality continue to increase globally because of
population aging, and there is a clear opportunity for better
preventive effort.1 Among those who survive a stroke or a
transient ischemic attack (TIA), the risk of further stroke is
high, ranging from 15% to 42% over 5 years.2,3 Indeed,
recurrent stroke accounts for up to 40% of all strokes.4
Recurrent stroke is associated with higher mortality than
ﬁrst stroke, and functional recovery is often poorer,5 so
secondary prevention matters. Lowering systolic blood
pressure (SBP) by 5 mm Hg or diastolic blood pressure
(DBP) by 2.5 mm Hg reduces the incidence of stroke by 15%
to 20%, independent of prevalent vascular disease and
hypertension.6
However, blood pressure control after stroke is suboptimal,
with up to 41% of patients having a SBP >140 mm Hg.7 Blood
pressure targets for secondary prevention have been recently
lowered to 130/80 mm Hg,8 and some guidelines9 suggest
treating all patients with a previous stroke or TIA with
antihypertensive medication regardless of blood pressure,
unless contraindicated. Patient adherence to antihypertensive
therapy is likely to be a major barrier to implementation of
these guidelines.10
In primary prevention, a range of interventions to improve
adherence have been evaluated. Simpliﬁcation of dosage
regimen improved adherence to antihypertensive drugs
although the effect on blood pressure is unclear.11 Where
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signiﬁcant effects on blood pressure have been reported,
notably in the Hypertension Detection and Follow-Up study,12
an organized system of regular reviews was linked to
medication intensiﬁcation, and medication adherence was
not measured.11,13 Evidence remains uncollated for people
with stroke who may be particularly motivated but face
special challenges in taking their medicines as prescribed. We
performed a systematic review of randomized controlled trials
of interventions that included a component to improve
adherence to antihypertensive drugs in adults with stroke/
TIA to assess the impact of these interventions on blood
pressure and adherence.
Methods
Eligible studies included adults with conﬁrmed history of
stroke/TIA, randomized to interventions including a compo-
nent to improve adherence to antihypertensive medications
and measuring blood pressure or patients’ adherence to
antihypertensive medications.
Search Method and Study Selection
We searched Medline (1966 to October 2012), Embase (1980
to October 2012), CINAHL (1981 to October 2012), PsycINFO
(1806 to October 2012), and BNI (1985 to October 2012).
Search terms covered adherence, prevention, hypertension,
clinical terms for TIA/stroke, and terms for randomized
controlled trial (search strategy in Table S1). We adapted the
search for each database without language restrictions.
Reference lists of all included articles were also searched
manually.
One reviewer (A.D.S.) screened all titles and abstracts, and
20% were checked independently by W.H., with differences
agreed by consensus. The full text was examined for articles
in which a deﬁnite decision to reject could not be made based
on title and abstract alone. Two reviewers (A.D.S. and W.H.)
independently assessed all full-text articles, and those not
meeting the inclusion criteria by both researchers were
excluded.
Two translators assessed foreign-language articles with
relevant titles or English abstracts. All translators were
familiar with medical literature and terminology. Validation
of the data extraction form was performed by A.D.S., W.H.,
A.L.K., and A.F.
Data Extraction
The data extraction form was created and standardized over 3
meetings between 2 reviewers (A.D.S. and W.H.) until
agreement was reached by comparing extractions indepen-
dently obtained on 3 randomly selected included studies.
Two authors (A.D.S., W.H.) independently extracted data
on blood pressure and antihypertensive adherence and
resolved disagreements through discussion.
A.D.S. and W.H. classiﬁed intervention and control strat-
egies independently. They initially used behavior change
techniques (BCTs) Taxonomy V114 to identify interven-
tion components, but could not extract meaningful data on
BCTs used because of poor reporting, particularly in relation
to patient-directed interventions like “education” and “life-
style.” Therefore, intervention strategies were described more
broadly, faithful to the intervention descriptions by the
authors. Strategies were grouped into verbal information/
advice on disease and secondary-prevention drug treat-
ment, goal setting, supply of printed information/advice
material, screening for depression, personalized instructions,
and integrated care (see data extraction elements in Table
S4).
Quality Assessment
A.D.S. and W.H. appraised each study independently for risk
of bias, using accepted guidance.15 We considered sequence
generation, allocation concealment, blinding of study person-
nel and participants, incomplete outcome data, selective
outcome reporting, adequacy of the power calculation, and
use of intention-to-treat analysis (Table S3).
Statistical Analysis
We calculated pooled effect estimates for systolic blood
pressure (SBP) and diastolic blood pressure (DBP) for 6 trials
in which these outcomes were reported. We ﬁtted random
effects meta-analyses models to allow for heterogeneity
between studies in RevMan. We used pooled difference in
mean improvement of blood pressure from the intervention
together with the pooled difference in mean improvement of
blood pressure from the control arms of the trials to
estimate the effect of the intervention on blood pressure
control. For each analysis, we calculated the I2 statistic to
estimate the proportion of the observed variance in effects
across studies that indicates real differences rather than
random error, with 95% conﬁdence intervals using Stata. We
used values of 25%, 50%, and 75% as boundary limits for
low, moderate, and high heterogeneity.16 Signiﬁcance was
set at P<0.05, and 95% conﬁdence intervals are quoted
throughout.
Not all the trials reported the necessary data directly, so
we transformed and estimated these as necessary (see
Cochrane Handbook for Systematic Reviews of Interventions,
version 5.1.0).15 If standard deviations of blood pressure
measures at follow-up were not supplied,17 we carried forward
the baseline values. If the studies reported 95% conﬁdence
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intervals only,18,19 we calculated standard deviations using
the following formula: standard deviation=(conﬁdence interval
[CI]9square root [n])/1.96.
For the blood pressure measurements in the meta-analy-
sis, we used data collected at follow-up times. In all studies
blood pressure measurements were recorded at a single
follow-up time after the end of the intervention. Follow-ups
were carried out straight after the last intervention session in
2 studies,20,21 2 months later in 3 trials,18,19,22 and 3 months
later in 1.17
We performed sensitivity analyses to explore the impact of
excluding:
1. Relatively small studies (with <50 participants per ran-
domization group).
2. Studies considered at high risk of bias.
3. Studies that did not measure adherence.
4. Studies that did not properly describe the adherence
component of the intervention.
Three trials included a measure of adherence. The range of
outcome measures and the diversity of metrics used to
ascertain adherence prevented pooling for meta-analysis.
Results
Study Selection
We included 8 articles referring to 7 separate randomized
controlled trials after screening 7518 titles and abstracts and
reviewing 48 full texts (Figure 1). Eight trials required further
consideration after full-text reading. We excluded 3 studies
that made no distinction between adherence to antihyperten-
sive and other medications.23–25 We also excluded 1 study
because the primary aim was to improve health professionals’
adherence to prescribing antihypertensives rather than
patients’ adherence26 and 2 further studies in which the
outcomes were measured in a population of patients with
cardiovascular events that included only a minority of patients
Figure 1. Study ﬂow. TIA indicates transient ischemic attack.
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with stroke.27,28 These trials were excluded after contacting
the authors and ﬁnding that separate outcome measures were
not available. We also assessed 2 foreign-language papers, 1
Chinese29 and 1 German.30 One was excluded as adherence
to antihypertensive medication was not measured, and the
other study because the intervention was aimed at improving
practitioners’ management of blood pressure rather than
patients’ adherence.
Eight trials that were identiﬁed as potentially eligible were
excluded as the results were not available at time of
submission (see study characteristics in Table S5).31–38
Participants’ Characteristics
In 7 trials, 1591 patients living in the community with an
average age between 63 and 74 years were randomized. All
trials except 139 excluded patients with signiﬁcant cognitive
impairment or with serious comorbidities (see inclusion
criteria from Table S2).
Two studies included only patients with a history of stroke,
whereas the other 5 had a different proportion of patients
with stroke and TIA (Figure 2, Table). The proportion of
people with prior diagnosis of hypertension varied from 43%
to 100%.
Caregivers received the intervention together with patients
in 2 studies.20,39 Their degree of involvement, though, was not
reported.
Intervention Characteristics
A wide range of interventions were evaluated (Table, Figure 2,
and Table S2). All interventions were complex with
multiple aims and components that were generally poorly
described.
There was considerable variation in terms of size, setting,
duration of intervention, and study population (Table and
Table S2). Most interventions included ≥4 face-to-face
sessions. Primary care doctors and nurses delivered the
intervention in 3 studies,18–20 pharmacists in 1,21 and a
researcher in 1.22 The intervention was delivered through a
computer in 1 study17 and by a written hard-copy “keeping
well plan” for patients and evidence-based secondary
prevention plan tailored to patients for general practitioners
(GPs) in another study.39 The interventions were delivered in a
variety of settings, including GP surgery, home, and the
hospital (Figure 2). Final follow-up was carried out between
0 and 3 months after the last intervention session.
In all studies interventions included information and advice
about stroke and the role of preventive drugs. In 5 studies this
information and advice were tailored to individual patient
characteristics according to their risk factors proﬁle for stroke
recurrence. A goal-setting technique was used in 3 studies,
with blood pressure targets assigned to patients.20–22 Three
studies supplied written information.18,22,39 Only 1 interven-
tion was explicitly theory based, using social-cognitive theory.
This intervention aimed to translate knowledge (of hyperten-
sion and its treatment) into effective patient behavior change
(improved adherence and BP control), using motivational
interviewing.22
Six trials included additional information/advice on treat-
ments other than antihypertensive drugs (cholesterol- and
glucose-lowering medications, anticoagulants),17,18,20–22,39
and 5 gave information on lifestyle risk factors (eg, smoking
cessation, weight reduction).17,18,20,22,39
Control Interventions
Control groups were described as receiving “usual care” in 4 of
7 studies. In the other studies, control care included generic
risk factor advice once from a stroke nurse specialist,18 health
education from a neurologist,17 and advice on healthy lifestyle
choices from the multidisciplinary stroke team.19
Study Quality
Study quality was variable (Table S3). All studies were judged
at risk of bias in at least 2 domains, but only 1 study21 was
judged to be at high risk of bias. Blinding of participants was
not possible with these types of intervention. Outcome
assessors were clearly blinded to treatment allocation in 3
studies.
Intervention Effects on Blood Pressure
Six studies17–22 examined the effect of interventions on systolic
and diastolic blood pressure (Table). Pooled analysis showed
that interventions were associated with a signiﬁcant (P=0.03)
reduction in SBP of 5.3 mm Hg (95% CI, 10.2 to
0.4 mm Hg), I2=67% (21% to 86%). Pooled data on difference
in mean DBP showed that interventions were associated with a
reduction of 2.5 mm Hg (95% CI, 5 to 0.1 mm Hg),
I2=47% (0% to 79%); P=0.05 (Figure 3).
Intervention Effect on Adherence to
Antihypertensive Medications
The effect of the intervention on patients’ adherence to
antihypertensive medications was small and not signiﬁcant in
any of the studies. Adherence was self-reported in 2
studies,19,39 undeﬁned in 1,17 and assessed from reﬁlling
prescription data (persistence of use of antihypertensives) in a
further study40 (see Table S3). Three trials17,19,40 reported on
both adherence and blood pressure changes and found no
effect on either outcome.
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In 1 trial19adherence, deﬁned as missing no fewer than 2
doses in the previous 2 weeks, was the same (98% versus
99%) in both arms; the second trial39 measured self-reported
adherence, and treatment with antihypertensives was 63%
and 66% in the intervention and control arms, respectively;
92% of patients in both control and intervention groups were
adherent to blood-pressure-lowering medications in the third
trial,17 although the method for measuring this outcome was
not reported. Another trial40 reported persistence with
antihypertensive therapy evaluated by comparing medication
details at 3-year follow-up, which was 95% and 97% for the
intervention and control groups, respectively.
The trials did not use objective measures of adherence
(eg, rate of prescription reﬁlls, electronic medication moni-
tors) or assess adherence among different classes (eg,
calcium antagonists, diuretics, beta-blockers, angiotensin
inhibitors).
Sensitivity Analysis of Blood Pressure Outcomes
After exclusion of relatively small studies17,22 from the
meta-analysis, signiﬁcant reductions in BP for the interven-
tion care compared with the usual care group were
observed (Figure 4A). Pooling data from the studies exclud-
ing the study at highest risk of bias showed smaller but still
signiﬁcant improvement in SBP, whereas the effect on DBP
was reduced (Figure 4B). A further analysis was performed
to check sensitivity to outcome, including only those studies
that measured adherence as outcome,17,18,40 failing to
detect a difference in either adherence or BP (Figure 4C).
A ﬁnal analysis on studies that fully described the adher-
ence intervention19,22 (Figure 4D) showed no effect on
SBP/DBP.
Discussion
There is little evidence to inform approaches to improve blood
pressure control through adherence to antihypertensive drugs
among patients with stroke or TIA. A rigorous search
discovered only 6 randomized controlled trials of relevant
interventions. All included multiple components and together
demonstrated clinically important effects on both systolic and
diastolic blood pressure. There was no evidence that this
effect was a result of improved adherence; few studies
measured adherence, and none found an intervention effect.
Populations
Populations were highly selected. A third of patients with
stroke have difﬁculty with communication,41 one ﬁfth of
whom suffer from aphasia.42 Stroke survivors may haveTa
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shortened attention spans or may experience deﬁcits in
short-term memory, comprehension, or engagement in com-
plex mental activities, requiring behavioral interventions
tailored to these impairments.43–47 Yet only 1 study39
included patients with cognitive deﬁcits and multiple morbid-
ities. Patients with signiﬁcant communication difﬁculties were
Figure 2. Representation of interventions from the 7 trials included in the review. See label on top right for explanation. Sizes correlated with
percentge of involvement. *Signiﬁcant blood pressure improvement in the intervention group. m Indicates months; TIA, transient ischemic attack;
HTN, hypertension; f/u, follow-up; GP, general practitioner.
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largely excluded. Perhaps not surprisingly, therefore, results
from this selected population with stroke are consistent with
those from similar trials in primary prevention of cardiovas-
cular disease.11–13,48
Only in 1 study39 were patients’ ethnicity and social class
recorded and primary outcomes adjusted for, with no
signiﬁcant effect on adherence. Patients’ “education” was
accounted for in 2 studies.17,21 The impact of culture,
socioeconomic status, health care coverage systems, and
availability of free care and medications was not studied,
although likely to have inﬂuenced adherence.
Interventions and Their Delivery
Interventions and their delivery were poorly described.
Interventions were commonly adapted from those in studies
of primary prevention of cardiovascular disease, including
components such as an organized system of regular review,
giving patients information or advice on disease and treat-
ment tailored to individual risk factor proﬁles, goal setting,
and motivational interviewing. Although educational interven-
tions were not promising in primary prevention,13 they were
incorporated into all secondary prevention trials as informa-
tion and advice on stroke and preventive drug treatments. Yet
simpliﬁcation of the overall drug regimen was not used
despite being the most promising strategy to improve
adherence to antihypertensive medications in primary
prevention trials,11 with a study suggesting feasibility in
patients with stroke.49 Future interventions may use the BCT
taxonomy14 to aid precise speciﬁcation of the behavior change
techniques used and the criteria deﬁned by the CONSORT
statement and Davidson et al50 to describe other important
intervention components (eg, mode of delivery, ﬁdelity).
There was a surprising lack of attention to epidemiological or
qualitative data available to inform interventions that might be
more effective with this patient group, perhaps because of the
selected study population as detailed above. One qualitative
study among patients with stroke identiﬁed priorities of longer
time for communication, simple language, short sentences and
large text, and uncluttered design for written materials.51
Family members or caregivers were only included as
recipients of the intervention in 2 trials despite evidence that
their involvement improves adherence52,53 and that they can
ﬁnd giving medicines difﬁcult.54
Greater attention to physician training in intensiﬁcation of
antihypertensive medication prescribing and simpliﬁcation
of overall drug regimens might also be fruitful. In the effective
Hypertension Detection and Follow-Up study, medication
intensiﬁcation rather than adherence was the main target.12 It
is seldom possible to untangle the effects of intervening on
medication adherence from regimen intensiﬁcation because
in most studies patients were advised to see their doctors for
medication review if their blood pressure was not at target,
and regimen intensiﬁcation was rarely measured.
Figure 3. Meta-analysis of effect of interventions on systolic blood pressure (A) and diastolic blood pressure (B). SD indicates standard
deviation; CI, conﬁdence interval.
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Similarly to primary prevention studies, nurse and phar-
macist involvement in a whole-systems approach to prescrib-
ing might be fruitful. Systems of regular reviews, linked to
medication intensiﬁcation and medication adherence coun-
seling by pharmacists or nurses lead to higher achievement of
blood pressure goals (conference abstracts).33,37
Measurement
Measurement of blood pressure and adherence was incon-
sistent across studies. Where adherence was measured,
self-report was used, and objective measures such as pill
count devices or electronic monitoring were absent.17,19,39
Interventions showed considerable heterogeneity in terms
of design and settings. Despite using appropriate meta-ana-
lytic techniques with random-effect models, we were unable
to control fully for these differences, and the small number
of studies meant that the degree of heterogeneity was
uncertain (the conﬁdence interval of I2 ranged from 0% to
86%).
During the period covered by the trials (2002–2011)
optimal goals for blood pressure after stroke/TIA changed
internationally as well as policies to reinforce them. For
example in the United Kingdom the introduction of the quality
and outcome frameworks payment to GPs in improving usual
care management of risk factors may partially explain the
failure to provide evidence of intervention effectiveness in
some studies.18,22,39 This could be attributed to improved
standards of care received by participants from both arms of
the trials.
Given the relatively small number of trials that we
identiﬁed and their small size (the largest only had 349
Figure 4. Sensitivity analysis to explore the impact of excluding: A, relatively small studies (with <50 participants per randomization group); B,
the study considered at high risk of bias; C, studies that did not measure adherence; D, studies that did not properly describe the adherence
component of the intervention. SBP indicates systolic blood pressure; DBP, diastolic blood pressure.
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participants), publication bias is a concern. It is likely to be
negative studies that are not published; therefore, this will not
affect our ﬁnding that no studies have demonstrated an
improvement in adherence, but may mean that we have
overestimated the value of multifactorial interventions on
blood pressure lowering in this population.
Future Work
Future work should improve on the weaknesses of current
evidence, yet review of the designs of 8 additional randomized
controlled trial protocols identiﬁed by the search strategy31–38
showed little sign of doing so. Trials still excluded participants
with signiﬁcant cognitive and communication impairments;
only 2 trial protocols took into account stroke disabilities in
the form of adding brief one-on-one sessions34 or by providing
practical problem solving.35
Although most protocols measured both blood pressure
and adherence, only 1 used the gold standard objective
measure of adherence with electronic pill containers.31
Caregivers were additional recipients of the intervention in
only 1 trial protocol35 for participants with stroke and
moderate to severe disabilities. Only 1 trial protocol speciﬁed
measurement along a hypothesized causal pathway,31 with
other studies continuing to test multifactorial interventions
with poorly speciﬁed multiple components, with no details of
how to isolate their effects on the outcomes measured.
Conclusions
On the basis of the limited data available, there is evidence
that multifactorial interventions can be effective in lowering
blood pressure in a selected population of patients with
stroke or TIA living in the community, although it is not
possible to isolate which component(s) of the interventions
account for this effect. The effects size is compatible with a
15% to 20% reduction in stroke recurrences.6
There is a paucity of studies of interventions to improve
medication adherence and blood pressure control after
stroke/TIA, when disabilities and cognitive impairment might
make adherence particularly difﬁcult.
Future studies should focus on characterizing the target
groups that might beneﬁt most from novel or better-
applied interventions to improve adherence and include
carers as well as patients and a whole healthcare system
approach to prescribing and taking medicines. Attention to
the reliability and objectivity of adherence and blood
pressure measurement is needed. Multifactorial intervention
design should enable measurement of intermediate out-
comes along a hypothesized causal pathway to allow
isolation of active ingredients and cost-effectiveness evalu-
ation of interventions.
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